Clinical trial
PAracetamol Treatment in Hypertension: Effect on Blood Pressure (PATH-BP) Study
NCT01997112 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PAracetamol Treatment in Hypertension: Effect on Blood Pressure (PATH-BP) Study
- Lead sponsor
- University of Edinburgh
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- October 31, 2019
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
blood pressure